If you’ve lost Lilly medicine due to the floods in Texas, please visit https://e.lilly/4eEr8PT or call 1-800-LillyRx (1-800-545-5979). #WeAreLilly
Eli Lilly and Company
Pharmaceutical Manufacturing
Indianapolis, Indiana 2,159,211 followers
About us
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- Website
-
http://www.lilly.com/
External link for Eli Lilly and Company
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Indianapolis, Indiana
- Type
- Public Company
- Specialties
- Pharmaceutical Development, Pharmaceuticals, Biotech, and Biopharmaceuticals
Locations
-
Primary
Get directions
Lilly Corporate Center
Indianapolis, Indiana 46285, US
Employees at Eli Lilly and Company
Updates
-
Nine years since his diagnosis of obstructive sleep apnea, Edgar has become a passionate advocate for sleep health. He also understands the impact sleep disorders like OSA can have on a relationship. For Edgar and his partner Frankie, communication is the key. This #PrideMonth, we’re sharing their story. https://e.lilly/44dKSVR #WeAreLilly
-
Rita Flynn is a lifelong storyteller. Now, instead of telling other people’s stories, she’s telling her own – and seeking to destigmatize what it’s like to live with early symptomatic Alzheimer’s disease. “The main thing I would recommend to people in this situation is don’t be afraid.” Learn more about her story, as we recognize Alzheimer’s and Brain Awareness Month: https://e.lilly/4mVtwpg #EndAlz #WeAreLilly
-
For people with diabetes, the daily regimen of insulin therapy can be difficult to manage. We’re trying to make it simpler – 100 years after we introduced the first insulin medicine. Today we presented detailed results from multiple late-stage studies of a potential once-weekly treatment option for type 2 diabetes. Read more: https://e.lilly/43TyZFJ #ADA2025
-
Type 2 diabetes is a complex, chronic condition that calls for different treatment approaches, including both oral and injectable medicines. Today, results of the first late-stage clinical study of a potential new type 2 diabetes pill were presented at the American Diabetes Association’s Scientific Sessions and published in the NEJM Group. Read more: https://e.lilly/4lhI8hd
-
Veer’s mother knew something was wrong with her child. Why was he always feeling weak? In resource-limited locations like Veer’s home in Maharashtra, India, it’s harder for families to quickly access health care that can give them answers. That’s where UNICEF and volunteers are helping on the ground, supporting local health care workers in better identifying and treating non-communicable diseases. Diagnosed with a heart defect, Veer and his family were able to correct the problem through surgery—and he’s once again living the active and healthy life every child deserves. There are 2 billion other kids worldwide living with non-communicable diseases that threaten their health. That’s why we continue to support UNICEF USA, which supports efforts to address non-communicable diseases through early prevention, detection, and treatment for children in resource-limited settings in low- and middle-income countries. Everyone should have a chance at better health. Read more: https://e.lilly/4n7vxyQ #WeAreLilly #HealthyStarts
-
For people with diverse skin tones like Lillian, moderate-to-severe eczema (atopic dermatitis) may appear differently, such as gray, purple or dark brown patches—which can contribute to delays in diagnosis. To address the unique needs of people with pigmented skin, we’re advancing research that deepens understanding of eczema in diverse patient populations from diagnosis to treatment. Watch Lillian’s story to learn why inclusive research is so important: https://e.lilly/4e3ra3A #WeAreLilly
-
Obesity is a chronic disease and people deserve clarity and support in their treatment journey. Today, we shared that the highest-approved doses of our obesity medicine will be available in single-dose vials on LillyDirect. This means every approved strength of our medicine will be available to eligible patients with a prescription, regardless of insurance, through LillyDirect Self Pay Pharmacy Solutions. Our goal: make it simpler, safer and more transparent for patients to access authentic medicine and stay on their prescribed treatment. Learn more: https://e.lilly/3FOwiMt
-
Imagine using the power of AI to help design medicines that target diseases no human has been able to solve. Or making connections in scientific data that are too hard for people to see – and what that could mean for tailoring medicines to a patient’s specific needs. Our chief digital guru, Diogo Rau , sat down with The Atlantic’s “Most Interesting Thing in AI” podcast to talk about how we’re using cutting-edge technology to create better medicines for the future. Check out the conversation at link below. #WeAreLilly
CEO @ The Atlantic | Co-Founder, Keynote Speaker
This week on the podcast: My conversation with Diogo Rau, Chief Digital Officer at Eli Lilly and Company, about using AI in drug discovery in 3 fascinating ways: 1. Teaching AI to "read" DNA like it might read text. 2. Creating custom proteins that could become new medicines. 3. Searching vast numbers of drug combinations—much more than a human ever could. Plus: while other companies were banning ChatGPT, Lilly encouraged employees to use it. Why? I also chat with PwC's Chief AI Officer Dan Priest. Listen to the episode, where Diogo also describes a slightly embarrassing email I sent out when we were classmates in college: https://lnkd.in/exXD_Gc2 Produced by Atlantic Re:think, our creative marketing studio, with PwC, the sponsor of this podcast.
-
James Zervios, Chief Operating Officer of Obesity Action Coalition, shares the damaging impact of weight bias in the media and why it's essential to portray people with obesity with dignity and respect. By partnering with OAC to launch a gallery of bias-free images, we hope to help change the way obesity is portrayed. Learn more: https://e.lilly/4kryfgT #WeAreLilly